NEW ORLEANS -- Aspirin got downgraded while heart-beneficial diabetes medications got a boost in updated primary prevention of atherosclerotic cardiovascular disease (ASCVD) guidelines.
Other key additions to the American College of Cardiology (ACC)/American Heart Association guidelines were prominent endorsements of team-based care, shared-decision making, and considering social determinants of health.
No comments:
Post a Comment